Correction to: Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol (Trials, (2022), 23, 1, (19), 10.1186/s13063-021-05951-w)

0Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Following the publication of the original article [1], we were notified that the author names have been incorrectly tagged (part of the last names had originally been tagged as first name).

Cite

CITATION STYLE

APA

Mera-Cordero, F., Bonet-Monne, S., Almeda-Ortega, J., García-Sangenís, A., Cunillera-Puèrtolas, O., Contreras-Martos, S., … Salvador-Gonzalez, B. (2022, December 1). Correction to: Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol (Trials, (2022), 23, 1, (19), 10.1186/s13063-021-05951-w). Trials. BioMed Central Ltd. https://doi.org/10.1186/s13063-022-06073-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free